These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 18268155)
1. Letter by Teerlink regarding article, "L-arginine supplementation in peripheral arterial disease: no benefit and possible harm". Teerlink T Circulation; 2008 Feb; 117(6):e157; author reply e158. PubMed ID: 18268155 [No Abstract] [Full Text] [Related]
2. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Wilson AM; Harada R; Nair N; Balasubramanian N; Cooke JP Circulation; 2007 Jul; 116(2):188-95. PubMed ID: 17592080 [TBL] [Abstract][Full Text] [Related]
3. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases. Herbaczyńska-Cedro K J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015 [TBL] [Abstract][Full Text] [Related]
4. New indications and controversies in arginine therapy. Coman D; Yaplito-Lee J; Boneh A Clin Nutr; 2008 Aug; 27(4):489-96. PubMed ID: 18640748 [TBL] [Abstract][Full Text] [Related]
5. Ask the doctor. My husband is taking arginine and citrulline supplements because he read that they will protect his heart and arteries. Should I try these supplements, too, or is this a waste of money? Creager MA Harv Heart Lett; 2009 Apr; 19(8):7. PubMed ID: 19681202 [No Abstract] [Full Text] [Related]
6. L-arginine, nitric oxide and collagen vascular diseases: a potential relationship? Das UN Nutrition; 1992; 8(5):371. PubMed ID: 1421787 [No Abstract] [Full Text] [Related]
8. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294 [TBL] [Abstract][Full Text] [Related]
9. Letter by Calonge and Petitti regarding article, "The United States Preventive Services Task Force recommendation statement on screening for peripheral arterial disease: more harm than benefit?". Calonge N; Petitti D Circulation; 2007 Feb; 115(8):e212; author reply e213. PubMed ID: 17325250 [No Abstract] [Full Text] [Related]
10. Letter to the editor re: JAMA article on L-arginine therapy in acute myocardial infarction. Boger RH Altern Med Rev; 2006 Jun; 11(2):91-2. PubMed ID: 16892511 [No Abstract] [Full Text] [Related]
11. No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes. Liu TH; Wu CL; Chiang CW; Lo YW; Tseng HF; Chang CK J Nutr Biochem; 2009 Jun; 20(6):462-8. PubMed ID: 18708287 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and vascular response to resistance exercise with L-arginine. Fahs CA; Heffernan KS; Fernhall B Med Sci Sports Exerc; 2009 Apr; 41(4):773-9. PubMed ID: 19276857 [TBL] [Abstract][Full Text] [Related]
13. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148 [TBL] [Abstract][Full Text] [Related]
14. Arginine: too much of a good thing may be bad! Marik PE Crit Care Med; 2006 Nov; 34(11):2844-7. PubMed ID: 17053570 [No Abstract] [Full Text] [Related]
15. The anabolic effect of arginine on proteins in skin wound and muscle is independent of nitric oxide production. Zhang XJ; Chinkes DL; Wolfe RR Clin Nutr; 2008 Aug; 27(4):649-56. PubMed ID: 18316142 [TBL] [Abstract][Full Text] [Related]
16. Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human platelets. Mendes-Ribeiro AC; Moss MB; Siqueira MA; Moraes TL; Ellory JC; Mann GE; Brunini TM Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1143-6. PubMed ID: 18505438 [TBL] [Abstract][Full Text] [Related]
17. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study". De Backer TL; Vander Stichele RH; Van Bortel LM Circulation; 2008 Sep; 118(10):e151. PubMed ID: 18765384 [No Abstract] [Full Text] [Related]
18. Evidence Supporting a Beneficial Role for Long-Term L-Arginine Supplementation in High-Risk Pregnancies. Germain AM; Valdés G; Romanik MC; Reyes MS Hypertension; 2004 Jul; 44(1):e1. PubMed ID: 15218885 [No Abstract] [Full Text] [Related]